Singapore markets open in 2 hours 45 minutes
Straits Times Index
3,200.03 -15.04 (-0.47%) S&P 500
4,274.51 +0.98 (+0.02%) Dow
33,550.27 -68.61 (-0.20%) Nasdaq
13,092.85 +29.24 (+0.22%) Bitcoin USD
26,294.20 +122.03 (+0.47%) CMC Crypto 200
562.03 -0.62 (-0.11%)
Iovance Biotherapeutics, Inc. (IOVA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.10B |
| Enterprise value | 929.95M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 3.55k |
| Price/book (mrq) | 1.90 |
| Enterprise value/revenue | 3.91k |
| Enterprise value/EBITDA | -2.30 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.09 |
| 52-week change 3 | -56.64% |
| S&P500 52-week change 3 | 14.91% |
| 52-week high 3 | 10.4100 |
| 52-week low 3 | 4.3750 |
| 50-day moving average 3 | 6.4288 |
| 200-day moving average 3 | 6.8539 |
Share statistics
| Avg vol (3-month) 3 | 6.2M |
| Avg vol (10-day) 3 | 14.76M |
| Shares outstanding 5 | 247.78M |
| Implied shares outstanding 6 | 247.78M |
| Float 8 | 209.83M |
| % held by insiders 1 | 0.33% |
| % held by institutions 1 | 91.40% |
| Shares short (14 Sept 2023) 4 | 30.51M |
| Short ratio (14 Sept 2023) 4 | 4.52 |
| Short % of float (14 Sept 2023) 4 | 13.43% |
| Short % of shares outstanding (14 Sept 2023) 4 | 12.31% |
| Shares short (prior month 14 Aug 2023) 4 | 27.53M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 25 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Jun 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -179,988.66% |
Management effectiveness
| Return on assets (ttm) | -39.14% |
| Return on equity (ttm) | -79.68% |
Income statement
| Revenue (ttm) | 238k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -417.38M |
| Net income avi to common (ttm) | -418.84M |
| Diluted EPS (ttm) | -2.0600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 250.89M |
| Total cash per share (mrq) | 1.01 |
| Total debt (mrq) | 80.71M |
| Total debt/equity (mrq) | 13.95% |
| Current ratio (mrq) | 3.10 |
| Book value per share (mrq) | 2.58 |
Cash flow statement
| Operating cash flow (ttm) | -335.09M |
| Levered free cash flow (ttm) | -187.97M |
© 2023 Yahoo. All rights reserved.
